IR Contacts

Investor Relations

Stephen Schultz - GW Pharmaceuticals
Vice President, Investor Relations

Direct Link: +1 917.280.2424
Mobile: +1 401.500.6570
sschultz@gwpharm.com

Financial Public Relations Advisor

Ben Atwell / Simon Conway - FTI Consulting
200 Aldersgate | Aldersgate Street
London, EC1A 4HD

+44 (0)20 3727 1000 (Direct)
+1 401.500.6570 (Mobile)
ben.atwell@fticonsulting.com / Simon.Conway@fticonsulting.com